Grow Therapy secured a $150 million Series D led by TCV and Goldman Sachs Alternatives.
- Amount
- $150M
- Stage
- Series D
- Announced
- 5 March 2026
- Leads
- TCV, Goldman Sachs Alternatives
- Checked
- Amount and date checked against the press source
Raised $150M in a Series D round, announced 5 March 2026.
Grow Therapy secured a $150 million Series D led by TCV and Goldman Sachs Alternatives.
Provides technology and services for mental healthcare providers and patients
MediaBoost gets your round in front of the press, future hires and your next investors.
Announce your round with MediaBoost